Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.

Seto A, Einarson T, Koren G.

Am J Perinatol. 1997 Mar;14(3):119-24.

PMID:
9259911
2.

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.

Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G.

Teratology. 2000 Dec;62(6):385-92.

PMID:
11091360
3.

Safety of metronidazole in pregnancy: a meta-analysis.

Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G.

Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):525-9.

PMID:
7856680
4.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
5.

The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis.

Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G.

Can J Clin Pharmacol. 2003 Winter;10(4):179-83.

PMID:
14712322
6.

The safety of metoclopramide use in the first trimester of pregnancy.

Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A.

N Engl J Med. 2009 Jun 11;360(24):2528-35. doi: 10.1056/NEJMoa0807154.

7.

Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study.

Loebstein R, Lalkin A, Addis A, Costa A, Lalkin I, Bonati M, Koren G.

J Allergy Clin Immunol. 1999 Nov;104(5):953-6.

PMID:
10550738
8.

Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.

Bar-Oz B, Diav-Citrin O, Shechtman S, Tellem R, Arnon J, Francetic I, Berkovitch M, Ornoy A.

Eur J Obstet Gynecol Reprod Biol. 2008 Nov;141(1):31-4. doi: 10.1016/j.ejogrb.2008.07.008. Epub 2008 Aug 29.

PMID:
18760873
9.

Is metronidazole teratogenic? A meta-analysis.

Caro-Patón T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodríguez Pinilla E.

Br J Clin Pharmacol. 1997 Aug;44(2):179-82.

10.

Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.

Gilbert C, Valois M, Koren G.

Fertil Steril. 2006 Sep;86(3):658-63. Epub 2006 Jul 31. Review.

PMID:
16879826
11.

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G.

Dig Dis Sci. 1996 Jun;41(6):1145-9.

PMID:
8654145
12.

Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis.

Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G.

Dig Dis Sci. 2002 Jul;47(7):1526-9.

PMID:
12141812
13.

Pregnancy outcome following maternal organic solvent exposure: a meta-analysis of epidemiologic studies.

McMartin KI, Chu M, Kopecky E, Einarson TR, Koren G.

Am J Ind Med. 1998 Sep;34(3):288-92.

PMID:
9698999
14.

Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study.

Diav-Citrin O, Shechtman S, Aharonovich A, Moerman L, Arnon J, Wajnberg R, Ornoy A.

J Allergy Clin Immunol. 2003 Jun;111(6):1239-43.

PMID:
12789223
15.
16.

Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis.

Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G.

Obstet Gynecol. 1995 Jan;85(1):141-9.

PMID:
7800312
17.

Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.

Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G.

Am J Obstet Gynecol. 2002 Dec;187(6):1623-30.

PMID:
12501074
18.

The safety of quinolones--a meta-analysis of pregnancy outcomes.

Bar-Oz B, Moretti ME, Boskovic R, O'Brien L, Koren G.

Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):75-8. doi: 10.1016/j.ejogrb.2008.12.007. Epub 2009 Jan 31. Review.

PMID:
19181435
19.

[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].

Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E.

Encephale. 2003 Nov-Dec;29(6):553-9. Review. French.

PMID:
15029090
20.

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Wurst KE, Poole C, Ephross SA, Olshan AF.

Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70. doi: 10.1002/bdra.20627.

PMID:
19739149

Supplemental Content

Support Center